Met Life Investment Management, LLC Sera Prognostics, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 17,254 shares of SERA stock, worth $137,514. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,254
Previous 7,532
129.08%
Holding current value
$137,514
Previous $44,000
204.55%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SERA
# of Institutions
64Shares Held
20.3MCall Options Held
120KPut Options Held
0-
Baker Bros. Advisors LP New York, NY5.43MShares$43.3 Million0.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$24.2 Million0.33% of portfolio
-
Interwest Venture Management CO2.42MShares$19.3 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$13.2 Million1.88% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$11.2 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $236M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...